A new trading day began on Monday, with Skye Bioscience Inc (NASDAQ: SKYE) stock price up 7.69% from the previous day of trading, before settling in for the closing price of $1.3. SKYE’s price has ranged from $1.14 to $5.75 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 42.99% over the last five years. Meanwhile, its annual earnings per share averaged -88.63%. With a float of $19.46 million, this company’s outstanding shares have now reached $30.99 million.
Skye Bioscience Inc (SKYE) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Skye Bioscience Inc is 39.29%, while institutional ownership is 25.60%. The most recent insider transaction that took place on Aug 22 ’25, was worth 582,936. In this transaction Director of this company sold 170,449 shares at a rate of $3.42, taking the stock ownership to the 57,493 shares. Before that another transaction happened on Aug 21 ’25, when Company’s Director sold 60,956 for $3.57, making the entire transaction worth $217,613. This insider now owns 63,963 shares in total.
Skye Bioscience Inc (SKYE) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.29 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -88.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -14.06% during the next five years compared to 42.99% growth over the previous five years of trading.
Skye Bioscience Inc (NASDAQ: SKYE) Trading Performance Indicators
Here are Skye Bioscience Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.29, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Skye Bioscience Inc (SKYE)
Analysing the last 5-days average volume posted by the [Skye Bioscience Inc, SKYE], we can find that recorded value of 0.45 million was lower than the volume posted last year of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 15.99%.
During the past 100 days, Skye Bioscience Inc’s (SKYE) raw stochastic average was set at 2.68%, which indicates a significant decrease from 34.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1093 in the past 14 days, which was lower than the 0.2967 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4751, while its 200-day Moving Average is $2.6834. Now, the first resistance to watch is $1.4533. This is followed by the second major resistance level at $1.5067. The third major resistance level sits at $1.5533. If the price goes on to break the first support level at $1.3533, it is likely to go to the next support level at $1.3067. Should the price break the second support level, the third support level stands at $1.2533.
Skye Bioscience Inc (NASDAQ: SKYE) Key Stats
With a market capitalization of 44.88 million, the company has a total of 32,057K Shares Outstanding. Currently, annual sales are 0 K while annual income is -26,570 K. The company’s previous quarter sales were 0 K while its latest quarter income was -17,620 K.
